ELECTROMEDICAL TECHNOLOGIES, INC.: net property, plant and equipment
Net property, plant and equipment for ELECTROMEDICAL TECHNOLOGIES, INC. Inspect selected reporting periods, original units and SEC filing links; download the financial history.
All ELECTROMEDICAL TECHNOLOGIES, INC. financial histories
What this measure means
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
Exact concept: us-gaap:PropertyPlantAndEquipmentNet. Each value is a balance at the reporting date, not a flow earned over a year. Different units remain separate; no currency conversion or interpolation is applied.
Coverage of this history
Selected reporting periods run from 2019-12-31 to 2023-12-31. The SEC response was captured on 2026-09-21.
This selected history ends more than two years before capture. Do not treat its final value as a current balance or current annual result. More recent filings may use another accounting tag; inspect the filings before drawing conclusions about the company.
Selected filing history
| Period start | Period end | Value | Unit | Filed | Source filing |
|---|---|---|---|---|---|
| At date | 2023-12-31 | 149,705 | USD | 2024-05-01 | 10-K · 0001410578-24-000581 |
| At date | 2022-12-31 | 705,469 | USD | 2024-05-01 | 10-K · 0001410578-24-000581 |
| At date | 2021-12-31 | 727,344 | USD | 2023-03-31 | 10-K · 0001410578-23-000555 |
| At date | 2020-12-31 | 749,219 | USD | 2022-03-31 | 10-K · 0001410578-22-000752 |
| At date | 2019-12-31 | 771,094 | USD | 2021-03-30 | 10-K · 0001104659-21-043965 |
Related financial histories
- ELECTROMEDICAL TECHNOLOGIES, INC.: total assets
- ELECTROMEDICAL TECHNOLOGIES, INC.: total liabilities
- ELECTROMEDICAL TECHNOLOGIES, INC.: stockholders equity
- ELECTROMEDICAL TECHNOLOGIES, INC.: cash and cash equivalents
- ELECTROMEDICAL TECHNOLOGIES, INC.: net income or loss
- ELECTROMEDICAL TECHNOLOGIES, INC.: operating cash flow
- ELECTROMEDICAL TECHNOLOGIES, INC.: contract revenue excluding tax
- ELECTROMEDICAL TECHNOLOGIES, INC.: financing cash flow
- ELECTROMEDICAL TECHNOLOGIES, INC.: retained earnings or deficit
- ELECTROMEDICAL TECHNOLOGIES, INC.: basic weighted-average shares
- ELECTROMEDICAL TECHNOLOGIES, INC.: diluted weighted-average shares
- ELECTROMEDICAL TECHNOLOGIES, INC.: basic earnings per share
- ELECTROMEDICAL TECHNOLOGIES, INC.: diluted earnings per share
- ELECTROMEDICAL TECHNOLOGIES, INC.: share-based compensation expense
- ELECTROMEDICAL TECHNOLOGIES, INC.: operating income or loss
- ELECTROMEDICAL TECHNOLOGIES, INC.: current assets
- ELECTROMEDICAL TECHNOLOGIES, INC.: interest expense
- ELECTROMEDICAL TECHNOLOGIES, INC.: current liabilities
- ELECTROMEDICAL TECHNOLOGIES, INC.: current accounts payable
- ELECTROMEDICAL TECHNOLOGIES, INC.: net current accounts receivable
- ELECTROMEDICAL TECHNOLOGIES, INC.: net inventory
- ELECTROMEDICAL TECHNOLOGIES, INC.: gross profit
- ELECTROMEDICAL TECHNOLOGIES, INC.: cost of revenue
- ELECTROMEDICAL TECHNOLOGIES, INC.: selling, general and administrative expense
- ELECTROMEDICAL TECHNOLOGIES, INC.: research and development expense
Inspect the source
- Entity
- ELECTROMEDICAL TECHNOLOGIES, INC. / CIK 0001715819
- Captured
- 2026-09-21T17:24:36.315Z
- SEC response SHA-256
2ad8df4a9c5fb16e050ace525a2934e53474d15f46925e8496da9b3607574d0f
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001715819.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))